Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07426432

Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy

Aim of this study: evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions.

Material and methods:

Type: Prospective, randomized split mouth controlled study.

Interventions:

Intervention Group (Experimental Side):

•Application of fluoride-releasing composite

Control Group (Control Side):

•Application of conventional composite

Outcome Measures:

Primary Outcome: Incidence and Severity of White Spot Lesions

Secondary Outcomes:

1. Periodontal Ligament (PDL) Health 2. Gingival Bleeding and Inflammation

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

16 year–24 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura University

Al Mansurah, Egypt

About this study

Aim of the Study:

The aim of this study is to evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions (WSLs) development during clear aligner therapy in comparison to a split-mouth controlled group.

Material and methods:

Study Design:

Each participant will have one side of the mouth assigned to fluoride-releasing composite intervention as attachments, while the contralateral side will be assigned to conventional composite as attachments.

Sample size calculation:

Sample size calculation was based on effect of fluoride-releasing composite resin on prevention of White Spot Lesions during Clear Aligner Therapy: that was retrieved from most similar research Abdullah et al. Using G power program version 3.1.9.7 to calculate sample size based on effect size of 1.08 that is based on mean area of white spots, using 2-tailed test, α error = 0.05 and power = 95% , the total calculated sample size will be 24 in each group. To mitigate the potential impact of an anticipated 20% dropout rate, the recruitment target was increased to 30 patients per treatment group, aiming to ensure adequate statistical power in the final analyzed sample.

Inclusion criteria

  • Patients aged 16-24 years.
  • Good general and oral health.
  • Mild dental crowding per arch (≤ 4 mm).

Exclusion criteria

  • Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
  • Patients with Cleft lip and palate.
  • Previous orthodontic treatment.
  • Dental fluorosis.
  • Hypocalcified teeth or visible demineralization.

Interventions:

  • Initial Oral Scan:

A 3D oral scan of the arch to be treated will be performed using a digital intraoral scanner

  • Aligner Fabrication:

Aligners will be fabricated using thermoforming techniques. Intervention Group (Experimental Side): application of a fluoride-releasing composite on the indicated side of the mouth as attachments.

Control Group (Control Side): application of conventional composite as attachments.

  • Aligner Placement: the aligners will be fitted, and patients will wear them continuously, except during eating and brushing.

Outcome Measures:

Primary Outcome: Incidence and Severity of White Spot Lesions Measured at base line, third (T1) and sixth (T2) months.

1.Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).

Secondary Outcome:

  • Periodontal Ligament (PDL) Health using: Pocket Depth Index (PDI)
  • Gingival Bleeding and Inflammation

Duration of the study:

•This study is suggested to be finished in 12 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 16-24 years.
  • Good general and oral health.
  • Mild dental crowding per arch (≤ 4 mm).

Exclusion criteria

  • Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders).
  • Patients with Cleft lip and palate.
  • Previous orthodontic treatment.
  • Dental fluorosis.
  • Hypocalcified teeth or visible demineralization.

Treatment and study plan

Application of fluoride-releasing composite

Other

using fluoride releasing composite for attachment construction

Application of conventional composite

Other

using non fluoridated composite for attachment construction

Primary outcomes

  1. White Spot Lesions

    Time frame: six months

    Incidence and Severity of White Spot Lesions Measured at baseline, third (T1) and sixth (T2) months, by Laser fluorescence (DIAGNOdent), lesion defined as having a numerical score equal to or higher than (14).

Secondary outcomes

  1. Periodontal Ligament (PDL) Health

    Time frame: six months

    Periodontal Ligament (PDL) Health using:

    • Pocket Depth Index (PDI), by periodontal probe
    • 1-3 mm: Healthy or mild inflammation.
    • 4-5 mm: Moderate periodontal disease.
    • ≥6 mm: Severe periodontal disease with potential bone loss.
  2. Gingival Bleeding and Inflammation

    Time frame: six months

    Gingival Bleeding Index (GBI) Dichotomous (yes/no bleeding) no=0 yes=1

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Official study title

Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy: A Controlled Split-Mouth Study

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 23, 2026
Registry last updated
Feb 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.